{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T02:44:08Z","timestamp":1768790648158,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"crossref","award":["W81XWH-09-1-0212"],"award-info":[{"award-number":["W81XWH-09-1-0212"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"crossref","award":["W81XWH-12-1-0414"],"award-info":[{"award-number":["W81XWH-12-1-0414"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute of Health","award":["U54CA143837"],"award-info":[{"award-number":["U54CA143837"]}]},{"name":"National Institute of Health","award":["U54CA151668"],"award-info":[{"award-number":["U54CA151668"]}]},{"name":"State of Texas CPRIT","award":["RP121071"],"award-info":[{"award-number":["RP121071"]}]},{"name":"Ernest Cockrell Jr. Distinguished Endowed Chair"},{"DOI":"10.13039\/100000916","name":"Golfers Against Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000916","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.jconrel.2014.04.057","type":"journal-article","created":{"date-parts":[[2014,5,10]],"date-time":"2014-05-10T03:00:17Z","timestamp":1399690817000},"page":"22-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Bone marrow endothelium-targeted therapeutics for metastatic breast cancer"],"prefix":"10.1016","volume":"187","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8374-4352","authenticated-orcid":false,"given":"Junhua","family":"Mai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaofeng","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guodong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Volk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh L.","family":"Lokesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varatharasa","family":"Thiviyanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Gorenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuewu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifa","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jconrel.2014.04.057_bb0005","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1158\/0008-5472.CAN-07-5644","article-title":"Subtypes of breast cancer show preferential site of relapse","volume":"68","author":"Smid","year":"2008","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.jconrel.2014.04.057_bb0010","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","article-title":"Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer","volume":"26","author":"Liedtke","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2014.04.057_bb0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3816\/CBC.2000.n.003","article-title":"Treatment of metastatic bone disease in breast cancer: bisphosphonates","volume":"1","author":"Diel","year":"2000","journal-title":"Clin. Breast Cancer"},{"issue":"8","key":"10.1016\/j.jconrel.2014.04.057_bb0020","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.jconrel.2014.04.057_bb0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3111\/13696998.2012.737883","article-title":"Relationship between incidence of fracture and health-related quality-of-life in metastatic breast cancer patients with bone metastasis","volume":"16","author":"Walker","year":"2013","journal-title":"J. Med. Econ."},{"issue":"2","key":"10.1016\/j.jconrel.2014.04.057_bb0030","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.breast.2009.12.001","article-title":"Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy","volume":"19","author":"Hines","year":"2010","journal-title":"Breast"},{"issue":"7084","key":"10.1016\/j.jconrel.2014.04.057_bb0035","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature04524","article-title":"Regulation of cancer cell migration and bone metastasis by RANKL","volume":"440","author":"Jones","year":"2006","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.jconrel.2014.04.057_bb0040","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1158\/1078-0432.CCR-11-3310","article-title":"Bone-related complications and quality of life in advanced breast cancer: results from a randomized phase III trial of denosumab versus zoledronic acid","volume":"18","author":"Martin","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"14","key":"10.1016\/j.jconrel.2014.04.057_bb0045","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/jnci\/djs263","article-title":"Effects of bone-targeted agents on cancer progression and mortality","volume":"104","author":"Coleman","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"issue":"9","key":"10.1016\/j.jconrel.2014.04.057_bb0050","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S1470-2045(08)70204-3","article-title":"Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy","volume":"9","author":"Gnant","year":"2008","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.jconrel.2014.04.057_bb0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF03033743","article-title":"Alterations of microvascular density in bone metastases of adenocarcinomas","volume":"10","author":"Lorincz","year":"2004","journal-title":"Pathol. Oncol. Res."},{"issue":"11","key":"10.1016\/j.jconrel.2014.04.057_bb0060","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/nm.2992","article-title":"Waking up hscs: a new role for E-selectin","volume":"18","author":"Moore","year":"2012","journal-title":"Nat. Med."},{"issue":"26","key":"10.1016\/j.jconrel.2014.04.057_bb0065","doi-asserted-by":"crossref","first-page":"6743","DOI":"10.1182\/blood-2011-07-343566","article-title":"Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow","volume":"118","author":"Zarbock","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jconrel.2014.04.057_bb0070","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/nm.2969","article-title":"Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance","volume":"18","author":"Winkler","year":"2012","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2014.04.057_bb0075","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jconrel.2011.09.084","article-title":"E-selectin as a target for drug delivery and molecular imaging","volume":"158","author":"Jubeli","year":"2012","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2014.04.057_bb0080","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jconrel.2012.02.018","article-title":"E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells","volume":"160","author":"Mitchell","year":"2012","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2014.04.057_bb0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nnano.2008.34","article-title":"Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications","volume":"3","author":"Tasciotti","year":"2008","journal-title":"Nat. Nanotechnol."},{"issue":"9\u201310","key":"10.1016\/j.jconrel.2014.04.057_bb0090","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/smll.201201510","article-title":"Multistage vectored sirna targeting ataxia-telangiectasia mutated for breast cancer therapy","volume":"9","author":"Xu","year":"2013","journal-title":"Small"},{"issue":"9","key":"10.1016\/j.jconrel.2014.04.057_bb0095","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1158\/0008-5472.CAN-09-3931","article-title":"Sustained small interfering RNA delivery by mesoporous silicon particles","volume":"70","author":"Tanaka","year":"2010","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.jconrel.2014.04.057_bb0100","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1158\/1078-0432.CCR-12-2764","article-title":"Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery","volume":"19","author":"Shen","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"36","key":"10.1016\/j.jconrel.2014.04.057_bb0105","doi-asserted-by":"crossref","first-page":"H278","DOI":"10.1002\/adma.201101541","article-title":"E-selectin-targeted porous silicon particle for nanoparticle delivery to the bone marrow","volume":"23","author":"Mann","year":"2011","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2014.04.057_bb0110","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/adhm.201100005","article-title":"Cooperative, nanoparticle-enabled thermal therapy of breast cancer","volume":"1","author":"Shen","year":"2012","journal-title":"Adv. Healthc. Mater."},{"issue":"3","key":"10.1016\/j.jconrel.2014.04.057_bb0115","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jconrel.2009.10.014","article-title":"Size and shape effects in the biodistribution of intravascularly injected particles","volume":"141","author":"Decuzzi","year":"2010","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.jconrel.2014.04.057_bb0120","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/cyto.a.20952","article-title":"Proinflammatory activation pattern of human umbilical vein endothelial cells induced by IL-1beta, TNF-alpha, and LPS","volume":"77","author":"Mako","year":"2010","journal-title":"Cytometry A"},{"key":"10.1016\/j.jconrel.2014.04.057_bb0125","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1749-6632.2002.tb04702.x","article-title":"Regulation of the metastatic process by E-selectin and stress-activated protein kinase-2\/p38","volume":"973","author":"Laferriere","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"7","key":"10.1016\/j.jconrel.2014.04.057_bb0130","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1172\/JCI44745","article-title":"The JAK2\/STAT3 signaling pathway is required for growth of CD44(+)CD24(\u2212) stem cell-like breast cancer cells in human tumors","volume":"121","author":"Marotta","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.jconrel.2014.04.057_bb0135","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/med.20101","article-title":"Stat3: a critical transcription activator in angiogenesis","volume":"28","author":"Chen","year":"2008","journal-title":"Med. Res. Rev."},{"issue":"27","key":"10.1016\/j.jconrel.2014.04.057_bb0140","doi-asserted-by":"crossref","first-page":"19301","DOI":"10.1074\/jbc.274.27.19301","volume":"274","author":"O'Brien","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2014.04.057_bb0145","first-page":"177","article-title":"Clinical significance of interleukin (il)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies","volume":"3","author":"Tawara","year":"2011","journal-title":"Cancer Manag. Res."},{"issue":"10","key":"10.1016\/j.jconrel.2014.04.057_bb0150","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1101\/gad.1061803","article-title":"In vitro propagation and transcriptional profiling of human mammary stem\/progenitor cells","volume":"17","author":"Dontu","year":"2003","journal-title":"Genes Dev."},{"issue":"8","key":"10.1016\/j.jconrel.2014.04.057_bb0155","doi-asserted-by":"crossref","first-page":"e30207","DOI":"10.1371\/journal.pone.0030207","article-title":"Selective small molecule stat3 inhibitor reduces breast cancer tumor-initiating cells and improves recurrence free survival in a human-xenograft model","volume":"7","author":"Dave","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jconrel.2014.04.057_bb0160","doi-asserted-by":"crossref","first-page":"e43628","DOI":"10.1371\/journal.pone.0043628","article-title":"Ionizing radiation induces stemness in cancer cells","volume":"7","author":"Ghisolfi","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jconrel.2014.04.057_bb0165","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/stem.1058","article-title":"Radiation-induced reprogramming of breast cancer cells","volume":"30","author":"Lagadec","year":"2012","journal-title":"Stem Cells"},{"issue":"6","key":"10.1016\/j.jconrel.2014.04.057_bb0170","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","article-title":"A multigenic program mediating breast cancer metastasis to bone","volume":"3","author":"Kang","year":"2003","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.jconrel.2014.04.057_bb0175","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI3523","article-title":"TGF-beta signaling blockade inhibits pthrp secretion by breast cancer cells and bone metastases development","volume":"103","author":"Yin","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.jconrel.2014.04.057_bb0180","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrd2372","article-title":"Strategies for the discovery and development of therapies for metastatic breast cancer","volume":"11","author":"Eckhardt","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.jconrel.2014.04.057_bb0185","doi-asserted-by":"crossref","first-page":"C1123","DOI":"10.1152\/ajpcell.00247.2008","article-title":"MDA-MB-231 produces atp-mediated icam-1-dependent facilitation of the attachment of carcinoma cells to human lymphatic endothelial cells","volume":"295","author":"Kawai","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"2","key":"10.1016\/j.jconrel.2014.04.057_bb0190","first-page":"155","article-title":"A phosphopeptide mimetic prodrug targeting the sh2 domain of Stat3 inhibits tumor growth and angiogenesis","volume":"10","author":"Auzenne","year":"2012","journal-title":"J. Exp. Ther. Oncol."},{"issue":"4","key":"10.1016\/j.jconrel.2014.04.057_bb0195","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.bbrc.2013.04.084","article-title":"AG490 inhibits NFATc1 expression and STAT3 activation during RANKL induced osteoclastogenesis","volume":"435","author":"Li","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2014.04.057_bb0200","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/leu.2011.236","article-title":"The vascular niche: home for normal and malignant hematopoietic stem cells","volume":"26","author":"Doan","year":"2012","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.jconrel.2014.04.057_bb0205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2217\/fon.09.138","article-title":"Emerging therapeutic targets in breast cancer bone metastasis","volume":"6","author":"Rose","year":"2010","journal-title":"Future Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2014.04.057_bb0210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10555-007-9109-4","article-title":"The bone microenvironment in metastasis; what is special about bone?","volume":"27","author":"Bussard","year":"2008","journal-title":"Cancer Metastasis Rev."},{"issue":"6","key":"10.1016\/j.jconrel.2014.04.057_bb0215","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1158\/0008-5472.CAN-11-2905","article-title":"Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition","volume":"72","author":"Gao","year":"2012","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.jconrel.2014.04.057_bb0220","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.4049\/jimmunol.1201161","article-title":"Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment","volume":"189","author":"Simpson","year":"2012","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.jconrel.2014.04.057_bb0225","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc2618","article-title":"Microenvironmental regulation of metastasis","volume":"9","author":"Joyce","year":"2009","journal-title":"Nat. Rev. Cancer"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914002909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914002909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T03:23:04Z","timestamp":1538623384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365914002909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":45,"alternative-id":["S0168365914002909"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.04.057","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone marrow endothelium-targeted therapeutics for metastatic breast cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.04.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}